# Effect of Esketamine on 95% Induction Dose of Remimazolam

> **NCT06303037** · PHASE4 · COMPLETED · sponsor: **Second Affiliated Hospital of Wenzhou Medical University** · enrollment: 80 (actual)

## Conditions studied

- Pediatric
- Gastroscopy
- ED95
- Sedation

## Interventions

- **DRUG:** Remimazolam besylate and low-dose Esketamine
- **DRUG:** Remimazolam besylate and Medium dose Esketamine

## Key facts

- **NCT ID:** NCT06303037
- **Lead sponsor:** Second Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-01
- **Primary completion:** 2024-08-29
- **Final completion:** 2024-12-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06303037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06303037, "Effect of Esketamine on 95% Induction Dose of Remimazolam". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06303037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*